Aspen Aerogels, Inc. Reports First Quarter 2025 Financial Results and Recent Business Highlights
1. Total revenue decreased 17% to $78.7 million year-over-year. 2. Net loss of $301.2 million includes a significant impairment charge. 3. PyroThin awarded contract signals growth in EV market with production by 2028. 4. Operating cash flow stands at $5.6 million, indicating liquidity support. 5. Q2 2025 revenue outlook estimates between $70 and $80 million.